Innate Pharma
IPH.PA
Exchange: | PA |
Currency | Euro |
ISIN: | FR0010331421 |
Primary Ticker: | IPH.PA |
Fiscal Year End: | December |
IPO Date: | 2006-11-01 |
International Domestic: | International |
Sector: | Healthcare |
Industry: | Biotechnology |
Gic Sector: | Health Care |
Gic Group: | Pharmaceuticals, Biotechnology & Life Sciences |
Gic Industry: | Biotechnology |
Gic Sub Industry: | Biotechnology |
Description: | Innate Pharma S.A., a biotechnology company, develops immunotherapies for cancer patients in France and internationally. The company's products include Lacutamab (IPH4102), an anti-KIR3DL2 antibody, which is in Phase II clinical trials for the treatment of cutaneous T-cell and peripheral T-cell lymphoma, as well as in Phase II clinical trials to treat refractory sézary syndrome; Monalizumab, an immune checkpoint inhibitor that is in Phase III clinical trial to treat advanced solid tumors comprising colorectal and lung cancer, as well as head and neck cancer; IPH5201, a blocking antibody that is in Phase II clinical trials targeting the CD39 immunosuppressive pathway; IPH5301, an anti-CD73 antibody targeting the immunosuppressive adenosine pathway to promote antitumor immunity; IPH6401, an BCMA-targeting NK cell engager; and IPH6101, a N Kp46-based NK cell engager that targets CD123 proprietary multi-specific antibody format; and IPH62, an B7-H3-targeting NK cell engager. Its products in preclinical trials are IPH43, an anti-MICA/B ADC and IPH45, an antibody drug conjugates (ADC); and IPH67, an undisclosed, multi-specific ANKET. The company has licensing and collaboration agreements with Astra Zeneca, Novo Nordisk A/S, Sanofi, and Orega Biotech; and co-development and license agreement with Med Immune Limited. Innate Pharma S.A. was incorporated in 1999 and is headquartered in Marseille, France. |
Address: | 117, Avenue de Luminy, Marseille, France, 13009 |
Code: | IPHA |
Exchange: | US |
Name: | Innate Pharma |
Website: | https://www.innate-pharma.com |
Full Time Employees: | 168 |
Updated On: | 2024-11-04 |
Highlights
Market Capitalization: | 135349744 |
Market Capitalization Mln: | 135.34 |
EBITDA: | -35959000 |
Wall Street Target Price: | 6.5 |
Book Value: | 0.35 |
Earnings Share: | -0.42 |
Most Recent Quarter: | 2024-06-30 |
Profit Margin: | -1.00 |
Operating Margin TTM: | -2.13 |
Return On Assets TTM: | -0.13 |
Return On Equity TTM: | -0.78 |
Revenue TTM: | 33788000 |
Revenue Per Share TTM: | 0.41 |
Quarterly Revenue Growth YOY: | -0.69 |
Gross Profit TTM: | 57674000 |
Diluted Eps TTM: | -0.42 |
Quarterly Earnings Growth YOY: | -0.74 |
Valuation
Price Sales TTM: | 4.00 |
Price Book MRQ: | 4.78 |
Enterprise Value: | 81482230 |
Enterprise Value Revenue: | 3.27 |
Enterprise Value Ebitda: | -9.78 |
Shares
Shares Outstanding: | 80950800 |
Shares Float: | 31561091 |
Percent Insiders: | 25.03 |
Percent Institutions: | 10.26 |
Technicals
Beta: | 0.78 |
52 Week High: | 2.8 |
52 Week Low: | 1.59 |
50 Day MA: | 1.96 |
200 Day MA: | 2.16 |
Earnings
Report Date: | 2025-05-23 |
Date: | 2025-03-31 |
Before After Market: | Before Market |
Currency: | EUR |
Report Date: | 2024-11-13 |
Date: | 2024-09-30 |
Currency: | EUR |
Report Date: | 2024-09-12 |
Date: | 2024-06-30 |
Before After Market: | Before Market |
Currency: | EUR |
Eps Estimate: | -0.38 |
Eps Difference: | 0.38 |
Surprise Percent: | 10 |
Report Date: | 2024-05-14 |
Date: | 2024-03-31 |
Before After Market: | Before Market |
Currency: | EUR |
Report Date: | 2024-03-21 |
Date: | 2023-12-31 |
Before After Market: | Before Market |
Currency: | EUR |
Eps Estimate: | -0.41 |
Eps Difference: | 0.41 |
Surprise Percent: | 10 |
Report Date: | 2023-10-19 |
Date: | 2023-09-30 |
Before After Market: | After Market |
Currency: | EUR |
Report Date: | 2023-09-14 |
Date: | 2023-06-30 |
Before After Market: | Before Market |
Currency: | EUR |
Eps Estimate: | -0.14 |
Eps Difference: | 0.14 |
Surprise Percent: | 10 |
Report Date: | 2023-05-09 |
Date: | 2023-03-31 |
Before After Market: | After Market |
Currency: | EUR |
Report Date: | 2023-03-23 |
Date: | 2022-12-31 |
Before After Market: | Before Market |
Currency: | EUR |
Eps Actual: | -0.73 |
Eps Estimate: | -0.32 |
Eps Difference: | -0.41 |
Surprise Percent: | -128.12 |
Report Date: | 2022-11-14 |
Date: | 2022-09-30 |
Before After Market: | Before Market |
Currency: | EUR |
Report Date: | 2022-08-17 |
Date: | 2022-06-30 |
Before After Market: | After Market |
Currency: | EUR |
Eps Actual: | 0.08 |
Eps Estimate: | -0.26 |
Eps Difference: | 0.34 |
Surprise Percent: | 130.76 |
Report Date: | 2022-05-10 |
Date: | 2022-03-31 |
Before After Market: | Before Market |
Currency: | EUR |
Report Date: | 2022-03-24 |
Date: | 2021-12-31 |
Before After Market: | Before Market |
Currency: | EUR |
Eps Actual: | -0.27 |
Eps Estimate: | -0.32 |
Eps Difference: | 0.05 |
Surprise Percent: | 15.62 |
Report Date: | 2021-10-26 |
Date: | 2021-09-30 |
Before After Market: | After Market |
Currency: | EUR |
Report Date: | 2021-08-30 |
Date: | 2021-06-30 |
Before After Market: | After Market |
Currency: | EUR |
Eps Actual: | -0.3 |
Eps Estimate: | -0.23 |
Eps Difference: | -0.07 |
Surprise Percent: | -30.43 |
Report Date: | 2021-05-11 |
Date: | 2021-03-31 |
Before After Market: | Before Market |
Currency: | EUR |
Report Date: | 2021-03-18 |
Date: | 2020-12-31 |
Before After Market: | Before Market |
Currency: | EUR |
Eps Actual: | -0.68 |
Eps Estimate: | -0.08 |
Eps Difference: | -0.6 |
Surprise Percent: | -75 |
Report Date: | 2020-11-17 |
Date: | 2020-09-30 |
Before After Market: | Before Market |
Currency: | EUR |
Eps Actual: | -0.08 |
Eps Estimate: | -0.08 |
Report Date: | 2020-09-08 |
Date: | 2020-06-30 |
Before After Market: | Before Market |
Currency: | EUR |
Eps Actual: | -0.07 |
Eps Estimate: | -0.37 |
Eps Difference: | 0.3 |
Surprise Percent: | 81.08 |
Report Date: | 2020-05-12 |
Date: | 2020-03-31 |
Before After Market: | Before Market |
Currency: | EUR |
Report Date: | 2020-03-10 |
Date: | 2019-12-31 |
Before After Market: | Before Market |
Currency: | EUR |
Eps Actual: | -0.16 |
Eps Estimate: | -0.08 |
Eps Difference: | -0.08 |
Surprise Percent: | -10 |
Report Date: | 2019-11-13 |
Date: | 2019-09-30 |
Before After Market: | Before Market |
Currency: | EUR |
Eps Actual: | 0.04 |
Eps Estimate: | -0.08 |
Eps Difference: | 0.12 |
Surprise Percent: | 15 |
Report Date: | 2019-09-13 |
Date: | 2019-06-30 |
Before After Market: | Before Market |
Currency: | EUR |
Eps Actual: | 0.2 |
Eps Estimate: | 0.32 |
Eps Difference: | -0.12 |
Surprise Percent: | -37. |
Report Date: | 2019-05-15 |
Date: | 2019-03-31 |
Before After Market: | Before Market |
Currency: | EUR |
Eps Estimate: | 0.22 |
Eps Difference: | -0.22 |
Surprise Percent: | -10 |
Report Date: | 2019-03-20 |
Date: | 2018-12-31 |
Before After Market: | Before Market |
Currency: | EUR |
Eps Actual: | 0.07 |
Eps Estimate: | 0.07 |
Report Date: | 2018-11-15 |
Date: | 2018-09-30 |
Before After Market: | Before Market |
Currency: | EUR |
Eps Actual: | 0.07 |
Eps Difference: | 0.07 |
Report Date: | 2018-09-14 |
Date: | 2018-06-30 |
Before After Market: | Before Market |
Currency: | EUR |
Eps Actual: | -0.28 |
Eps Estimate: | -0.64 |
Eps Difference: | 0.36 |
Surprise Percent: | 56.2 |
Report Date: | 2018-05-16 |
Date: | 2018-03-31 |
Before After Market: | Before Market |
Currency: | EUR |
Report Date: | 2018-03-08 |
Date: | 2017-12-31 |
Before After Market: | Before Market |
Currency: | EUR |
Eps Actual: | -0.46 |
Eps Estimate: | -0.66 |
Eps Difference: | 0.2 |
Surprise Percent: | 30.30 |
Report Date: | 2017-11-15 |
Date: | 2017-09-30 |
Before After Market: | Before Market |
Currency: | EUR |
Report Date: | 2017-09-18 |
Date: | 2017-06-30 |
Before After Market: | Before Market |
Currency: | EUR |
Eps Actual: | -0.43 |
Eps Estimate: | -0.27 |
Eps Difference: | -0.16 |
Surprise Percent: | -59.25 |
Report Date: | 2017-05-15 |
Date: | 2017-03-31 |
Before After Market: | Before Market |
Currency: | EUR |
Report Date: | 2017-03-07 |
Date: | 2016-12-31 |
Before After Market: | Before Market |
Currency: | EUR |
Eps Estimate: | -0.42 |
Eps Difference: | 0.42 |
Surprise Percent: | 10 |
Report Date: | 2015-02-19 |
Date: | 2014-12-31 |
Before After Market: | After Market |
Currency: | EUR |
Eps Estimate: | -0.1 |
Eps Difference: | 0.1 |
Surprise Percent: | 10 |
Report Date: | 2014-09-17 |
Date: | 2014-06-30 |
Before After Market: | After Market |
Currency: | EUR |
Eps Estimate: | -0.19 |
Eps Difference: | 0.19 |
Surprise Percent: | 10 |
Report Date: | 2014-02-11 |
Date: | 2013-12-31 |
Currency: | EUR |
Eps Estimate: | -0.06 |
Eps Difference: | 0.06 |
Surprise Percent: | 10 |
Date: | 2014-12-31 |
Period: | +1y |
Revenue Estimate Avg: | 7623000.00 |
Revenue Estimate High: | 9300000.00 |
Revenue Estimate Number Of Analysts: | 4.00 |
Revenue Estimate Growth: | -0.54 |
Eps Trend7days Ago: | -0.33 |
Eps Trend30days Ago: | -0.33 |
Eps Trend60days Ago: | -0.33 |
Eps Trend90days Ago: | -0.33 |
Eps Revisions Down Last7days: | 1.00 |
Eps Revisions Down Last30days: | 1.00 |
Date: | 2013-12-31 |
Revenue Estimate Avg: | 16652000.00 |
Revenue Estimate High: | 15320000.00 |
Revenue Estimate Number Of Analysts: | 4.00 |
Revenue Estimate Growth: | 0.16 |
Eps Trend7days Ago: | -0.11 |
Eps Trend30days Ago: | -0.11 |
Eps Trend60days Ago: | -0.11 |
Eps Trend90days Ago: | -0.11 |
Date: | 2013-09-30 |
Period: | +1q |
Date: | 2013-06-30 |
Revenue Estimate Low: | 7000000.00 |
Revenue Estimate High: | 7000000.00 |
Revenue Estimate Number Of Analysts: | 1.00 |
Eps Trend7days Ago: | -0.06 |
Eps Trend30days Ago: | -0.06 |
Eps Trend60days Ago: | -0.06 |
Eps Trend90days Ago: | -0.06 |
Date: | 2024-09-30 |
Date: | 2023-12-31 |
Date: | 2022-12-31 |
Eps Actual: | -0.6 |
Date: | 2021-12-31 |
Eps Actual: | -0.5 |
Date: | 2020-12-31 |
Eps Actual: | -0.8 |
Date: | 2019-12-31 |
Date: | 2018-12-31 |
Eps Actual: | -0.1 |
Date: | 2017-12-31 |
Eps Actual: | -0.8 |
Date: | 2016-12-31 |
Date: | 2014-12-31 |
Date: | 2013-12-31 |